ARTICLE | Clinical News
Tepadina thiotepa regulatory update
March 29, 2010 7:00 AM UTC
The European Medicines Agency (EMA) approved an MAA from Adienne for Tepadina thiotepa as a conditioning treatment prior to autologous or allogeneic hematopoietic progenitor cell transplantation. The ...